Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies

Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies

Background: With prostate cancer being the fifth-greatest cause of cancer mortality in 2020, there is a dire need to expand the available treatment options. Castration-resistant prostate cancer (CRPC) progresses despite androgen depletion therapy. The mechanisms of resistance are yet to be fully dis...

Full description

Bibliographic Details
Main Authors: Rajeev K. Singla, Pooja Sharma, Ankit Kumar Dubey, Rohit Gundamaraju, Dinesh Kumar, Suresh Kumar, Reecha Madaan, Richa Shri, Christos Tsagkaris, Salvatore Parisi, Shikha Joon, Shailja Singla, Mohammad Amjad Kamal, Bairong Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
castration-resistant prostate cancer (CRPC)
hormone-sensitive cancer
advance staged cancer
natural products (NP)
natural anticancer agents
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.732266/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.732266/full

Similar Items